Global Psoriatic Arthritis Therapeutics Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Psoriatic Arthritis Therapeutics Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Psoriatic Arthritis Therapeutics Drug by Country/Region, 2017, 2022 & 2028

2.2 Psoriatic Arthritis Therapeutics Drug Segment by Type

2.2.1 NF Inhibitors

2.2.2 Interleukin Inhibitors

2.2.3 PDE4 Inhibitors

2.2.4 Others

2.3 Psoriatic Arthritis Therapeutics Drug Sales by Type

2.3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2017-2022)

2.4 Psoriatic Arthritis Therapeutics Drug Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Psoriatic Arthritis Therapeutics Drug Sales by Application

2.5.1 Global Psoriatic Arthritis Therapeutics Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2017-2022)

3 Global Psoriatic Arthritis Therapeutics Drug by Company

3.1 Global Psoriatic Arthritis Therapeutics Drug Breakdown Data by Company

3.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Company (2020-2022)

3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Company (2020-2022)

3.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Company (2020-2022)

3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company (2020-2022)

3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Company

3.4 Key Manufacturers Psoriatic Arthritis Therapeutics Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Psoriatic Arthritis Therapeutics Drug Product Location Distribution

3.4.2 Players Psoriatic Arthritis Therapeutics Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Psoriatic Arthritis Therapeutics Drug by Geographic Region

4.1 World Historic Psoriatic Arthritis Therapeutics Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Geographic Region

4.2 World Historic Psoriatic Arthritis Therapeutics Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Country/Region

4.3 Americas Psoriatic Arthritis Therapeutics Drug Sales Growth

4.4 APAC Psoriatic Arthritis Therapeutics Drug Sales Growth

4.5 Europe Psoriatic Arthritis Therapeutics Drug Sales Growth

4.6 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Growth

5 Americas

5.1 Americas Psoriatic Arthritis Therapeutics Drug Sales by Country

5.1.1 Americas Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)

5.1.2 Americas Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)

5.2 Americas Psoriatic Arthritis Therapeutics Drug Sales by Type

5.3 Americas Psoriatic Arthritis Therapeutics Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Psoriatic Arthritis Therapeutics Drug Sales by Region

6.1.1 APAC Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022)

6.1.2 APAC Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022)

6.2 APAC Psoriatic Arthritis Therapeutics Drug Sales by Type

6.3 APAC Psoriatic Arthritis Therapeutics Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Psoriatic Arthritis Therapeutics Drug by Country

7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)

7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)

7.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type

7.3 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug by Country

8.1.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type

8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Psoriatic Arthritis Therapeutics Drug

10.3 Manufacturing Process Analysis of Psoriatic Arthritis Therapeutics Drug

10.4 Industry Chain Structure of Psoriatic Arthritis Therapeutics Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Psoriatic Arthritis Therapeutics Drug Distributors

11.3 Psoriatic Arthritis Therapeutics Drug Customer

12 World Forecast Review for Psoriatic Arthritis Therapeutics Drug by Geographic Region

12.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Region

12.1.1 Global Psoriatic Arthritis Therapeutics Drug Forecast by Region (2023-2028)

12.1.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Psoriatic Arthritis Therapeutics Drug Forecast by Type

12.7 Global Psoriatic Arthritis Therapeutics Drug Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Psoriatic Arthritis Therapeutics Drug Product Offered

13.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Janssen Biotech

13.2.1 Janssen Biotech Company Information

13.2.2 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Offered

13.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Janssen Biotech Main Business Overview

13.2.5 Janssen Biotech Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Psoriatic Arthritis Therapeutics Drug Product Offered

13.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Amgen

13.4.1 Amgen Company Information

13.4.2 Amgen Psoriatic Arthritis Therapeutics Drug Product Offered

13.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen Main Business Overview

13.4.5 Amgen Latest Developments

13.5 CELGENE CORPORATION

13.5.1 CELGENE CORPORATION Company Information

13.5.2 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Offered

13.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CELGENE CORPORATION Main Business Overview

13.5.5 CELGENE CORPORATION Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Psoriatic Arthritis Therapeutics Drug Product Offered

13.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Eli Lilly

13.7.1 Eli Lilly Company Information

13.7.2 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Offered

13.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eli Lilly Main Business Overview

13.7.5 Eli Lilly Latest Developments

13.8 UCB

13.8.1 UCB Company Information

13.8.2 UCB Psoriatic Arthritis Therapeutics Drug Product Offered

13.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 UCB Main Business Overview

13.8.5 UCB Latest Developments

13.9 Biogen

13.9.1 Biogen Company Information

13.9.2 Biogen Psoriatic Arthritis Therapeutics Drug Product Offered

13.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biogen Main Business Overview

13.9.5 Biogen Latest Developments

13.10 Bristol-Myers Squibb

13.10.1 Bristol-Myers Squibb Company Information

13.10.2 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Offered

13.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bristol-Myers Squibb Main Business Overview

13.10.5 Bristol-Myers Squibb Latest Developments

14 Research Findings and Conclusion

Table 1. Psoriatic Arthritis Therapeutics Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Psoriatic Arthritis Therapeutics Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of NF Inhibitors

Table 4. Major Players of Interleukin Inhibitors

Table 5. Major Players of PDE4 Inhibitors

Table 6. Major Players of Others

Table 7. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)

Table 8. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

Table 9. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)

Table 13. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Table 14. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022)

Table 15. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Psoriatic Arthritis Therapeutics Drug Sales by Company (2020-2022) & (K Units)

Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Company (2020-2022)

Table 19. Global Psoriatic Arthritis Therapeutics Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Psoriatic Arthritis Therapeutics Drug Producing Area Distribution and Sales Area

Table 23. Players Psoriatic Arthritis Therapeutics Drug Products Offered

Table 24. Psoriatic Arthritis Therapeutics Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Psoriatic Arthritis Therapeutics Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Psoriatic Arthritis Therapeutics Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Psoriatic Arthritis Therapeutics Drug Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Psoriatic Arthritis Therapeutics Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)

Table 36. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)

Table 40. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)

Table 42. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022) & (K Units)

Table 44. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)

Table 48. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)

Table 50. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)

Table 52. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)

Table 56. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)

Table 58. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis Therapeutics Drug

Table 68. Key Market Challenges & Risks of Psoriatic Arthritis Therapeutics Drug

Table 69. Key Industry Trends of Psoriatic Arthritis Therapeutics Drug

Table 70. Psoriatic Arthritis Therapeutics Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Psoriatic Arthritis Therapeutics Drug Distributors List

Table 73. Psoriatic Arthritis Therapeutics Drug Customer List

Table 74. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Psoriatic Arthritis Therapeutics Drug Sales Market Forecast by Region

Table 76. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. AbbVie Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. AbbVie Psoriatic Arthritis Therapeutics Drug Product Offered

Table 96. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. AbbVie Main Business

Table 98. AbbVie Latest Developments

Table 99. Janssen Biotech Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Offered

Table 101. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Janssen Biotech Main Business

Table 103. Janssen Biotech Latest Developments

Table 104. Novartis Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Novartis Psoriatic Arthritis Therapeutics Drug Product Offered

Table 106. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Novartis Main Business

Table 108. Novartis Latest Developments

Table 109. Amgen Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Amgen Psoriatic Arthritis Therapeutics Drug Product Offered

Table 111. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Amgen Main Business

Table 113. Amgen Latest Developments

Table 114. CELGENE CORPORATION Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Offered

Table 116. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. CELGENE CORPORATION Main Business

Table 118. CELGENE CORPORATION Latest Developments

Table 119. Pfizer Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Pfizer Psoriatic Arthritis Therapeutics Drug Product Offered

Table 121. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Pfizer Main Business

Table 123. Pfizer Latest Developments

Table 124. Eli Lilly Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Offered

Table 126. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Eli Lilly Main Business

Table 128. Eli Lilly Latest Developments

Table 129. UCB Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. UCB Psoriatic Arthritis Therapeutics Drug Product Offered

Table 131. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. UCB Main Business

Table 133. UCB Latest Developments

Table 134. Biogen Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Biogen Psoriatic Arthritis Therapeutics Drug Product Offered

Table 136. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Biogen Main Business

Table 138. Biogen Latest Developments

Table 139. Bristol-Myers Squibb Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Offered

Table 141. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Bristol-Myers Squibb Main Business

Table 143. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Picture of Psoriatic Arthritis Therapeutics Drug

Figure 2. Psoriatic Arthritis Therapeutics Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Psoriatic Arthritis Therapeutics Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of NF Inhibitors

Figure 10. Product Picture of Interleukin Inhibitors

Figure 11. Product Picture of PDE4 Inhibitors

Figure 12. Product Picture of Others

Figure 13. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2021

Figure 14. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2022)

Figure 15. Psoriatic Arthritis Therapeutics Drug Consumed in Hospital Pharmacies

Figure 16. Global Psoriatic Arthritis Therapeutics Drug Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 17. Psoriatic Arthritis Therapeutics Drug Consumed in Retail Pharmacies

Figure 18. Global Psoriatic Arthritis Therapeutics Drug Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 19. Psoriatic Arthritis Therapeutics Drug Consumed in Online Pharmacies

Figure 20. Global Psoriatic Arthritis Therapeutics Drug Market: Online Pharmacies (2017-2022) & (K Units)

Figure 21. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application in 2021

Figure 23. Psoriatic Arthritis Therapeutics Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company in 2021

Figure 25. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units)

Figure 30. Americas Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units)

Figure 32. APAC Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units)

Figure 34. Europe Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021

Figure 38. Americas Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021

Figure 39. United States Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2021

Figure 44. APAC Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions in 2021

Figure 45. China Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021

Figure 52. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021

Figure 53. Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Psoriatic Arthritis Therapeutics Drug in 2021

Figure 66. Manufacturing Process Analysis of Psoriatic Arthritis Therapeutics Drug

Figure 67. Industry Chain Structure of Psoriatic Arthritis Therapeutics Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles